DMT:CC News and Press, Small Pharma Inc.

2024-03-27 17:08:02 ET The world is facing a mental health crisis. Today, one in six individuals are likely to suffer from an episode of major depression during their lifetime that could significantly impact their relationships, work and health. Add to that the substantial negative impact t...

2024-03-27 17:08:02 ET Help for mental health sufferers Small Pharma is a neuropharmaceutical company. They specialize in IP led development of novel treatments for mental health conditions, with a focus on depression. Small Pharma initiated a clinical program into DMT-assiste...

TSX Venture Exchange Stock Maintenance Bulletins Canada NewsWire VANCOUVER, BC , Oct. 24, 2023 /CNW/ - TSX VENTURE COMPANIES MINTO METALS CORP.  ("MNTO") BULLETIN TYPE: Delist BULLETIN DATE: October 24, 2023 T...

This news release constitutes a “designated news release” for the purposes of Cybin’s prospectus supplements each dated August 23, 2023, to its short form base shelf prospectus dated August 17, 2023. - Combined portfolios create the industry’s largest, most adv...

• Shareholders overwhelmingly vote in favour of Cybin’s acquisition of Small Pharma, supporting the combined company’s vision to build an international clinical-stage leader in psychedelic-based therapeutics LONDON, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Small Pharma Inc. ...

Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (“ Small Pharma ”), a biotechnology company focused on short-duration psychedelic-assisted therapies for mental health conditions and Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“ Cybin ”), a clinical-stage biopharma...

GoldMining Inc. (GOLD:CA) is expected to report $-0.02 for Q3 2023 Small Pharma Inc. (DMT:CA) is expected to report for Q2 2024 IntelliPharmaCeutics International Inc. (IPCI:CA) is expected to report for Q1 2024

Small Pharma Inc. (DMT:CA) is expected to report for Q2 2024

• Shareholders overwhelmingly vote in favour of Cybin’s acquisition of Small Pharma LONDON, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a biotechnology company focus...

LONDON, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Mr. Peter Rands disposed of an aggregate of 1,532,001 common shares in the capital of Small Pharma Inc. (the “ Company ”) between September 25, 2023 and September 27, 2023 at an average price of $0.177 per common share for aggregate proc...